FLCN mutations disrupt cellular homeostasis by impairing mitochondrial biogenesis and metabolism, leading to diverse histologic and clinical phenotypes depending on the tumor type and context [7,13,14,15,16]. The gene discussed is FLCN; the disease is neoplasm.